Science

Feb 15, 2025, 10:35

Myeloma Paper of the Day, February 15th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Final analysis of MAIA patient-reported outcomes finds sustained Improvement in health-related quality of life in transplant-ineligible newly diagnosed myeloma treated with daratumumab/len/dex vs. len/dex doublet.”

“Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: MAIA Final Analysis of Patient-Reported Outcomes”

Authors: Aurore Perrot, Thierry Facon, Torben Plesner, Fredrik Borgsten, Katja Weisel et al.

More posts featuring Robert Orlowski.

Aurore Perrot cancer Fredrik Borgsten Katja Weisel multiple myeloma Myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Thierry Facon Torben Plesner

Paco Arango: Casa Aladina - pioneering space in Europe for children with cancer

Andras Kulja: Europe is facing a healthcare crisis

ACT for Children: Tackling Inequities in Childhood Cancer Through Unique Global Collaboration

Richard Gere and Alejandra Gere to Join Second Global OncoThon on February 15 for Fight Against Childhood Cancer

Mesothelioma Guideline Updates from ASCO 2024: Key Advances in Diagnosis and Treatment